首页> 外文期刊>Chinese Journal of Clinical Oncology >Studies on the Distribution and Radioimmunoimaging of ~(99m)Tc-Labeled 5-Fluorouracil Loaded Immunological Nanoparticles in Tissues and Human Gastric Carcinoma Xenografts
【24h】

Studies on the Distribution and Radioimmunoimaging of ~(99m)Tc-Labeled 5-Fluorouracil Loaded Immunological Nanoparticles in Tissues and Human Gastric Carcinoma Xenografts

机译:〜(99m)Tc标记的5-氟尿嘧啶免疫纳米粒子在组织和人胃癌异种移植物中的分布和放射免疫成像研究

获取原文
           

摘要

OBJECTIVE To explore the method of preparation of ~(99m)Tc labeled Anti VEGF McAb 5-FU loaded polylactic acid nanoparticles (9~(99m)Tc-5-FU-Ab-NPs), and investigate the biological distribution of the nanoparticles in human gastric carcinoma xenografts.rnMETHODS AntiVEGF monoclonal antibodyes (MCAB) in 5-FU-Ab-NPs were labeled with 9~(99m)Tc using a modified Schwarz method. After isolation of the 9~(99m)Tc-5-FU-Ab-NPs using a Sephadex G-250 column, the labeling percentage and radiochemical purity were determined using paper chromatography. The immunocompetence of the 9~(99m)Tc-5-FU-Ab-NPs as tumor markers was determined using ELISA and immunohistochemistry. 9~(99m)Tc-5-FU-Ab-NPs (experimental group), 9~(99m)Tc-labelled murine multiclonal IgG loaded polylactic acid and nanoparticles (control group) were injected via the tail vein into SCID mice bearing human gastric carcinoma. A radio-immunity ECT image was developed at 2 and 6 h after the injection. Following the ECT imaging, the mice were sacrificed, their tissue and tumor radioactivity distribution determined, and percentage of the injected-dose pergram (%ID/g) and tumor/ nontumor (T/NT) ratio calculated. High performance liquid chromatography (HPLC) was used to determine the 5-FU concentration in the tumor tissue and blood in the mice of both groups.rnRESULTS The percentage of 9~(99m)Tc-5-FU-Ab-NPs labeling was 90%~95%. There was no obvious decrease in the antibody activity before and after labeling. The radio-immuno-imaging (RII) showed that the tumor image had developed 2 h after injection of the ~(99m)Tc-5-FU-Ab-NPs, and with time it was clearer at the 6th hour following the injection. The %ID/g of the tumor tissue at both 2 h and 6 h after the injection was significantly higher compared to the control group. The tumor %ID/g and the tumor to blood activity ratio (TB) of the experimental group at 6 h following the injection in creased compared to that at 2 h, and at the same time, 5-FU concentration in the tumor of the experimental group continuously increased over time, and showed a significant difference compared to the 5-FU concentration in the tumor of the control group.rnCONCLUSION The 9~(99m)Tc-5-FU-Ab-NPs prepared in this study are adequate to meet the demands of the RIl, and the immune targeting ability of the anti-VEGF MCAB is reliable. Six hours after injection, the 9~(99m)Tc-5-FU-Ab-NPs showed a relatively high specific concentration shadow in the human gastric carcinoma xenografts.
机译:目的探讨〜(99m)Tc标记的抗VEGF McAb 5-FU负载聚乳酸纳米颗粒(9〜(99m)Tc-5-FU-Ab-NPs)的制备方法,并探讨其在体内的生物学分布。使用改良的Schwarz方法,用9〜(99m)Tc标记5-FU-Ab-NPs中的rnMETHODS抗VEGF单克隆抗体(MCAB)。使用Sephadex G-250色谱柱分离9〜(99m)Tc-5-FU-Ab-NPs后,用纸色谱法测定标记百分比和放射化学纯度。采用ELISA和免疫组化方法检测9〜(99m)Tc-5-FU-Ab-NPs作为肿瘤标志物的免疫能力。通过尾静脉将9〜(99m)Tc-5-FU-Ab-NPs(实验组),9〜(99m)Tc标记的鼠多克隆IgG负载的聚乳酸和纳米颗粒(对照组)注射入荷人SCID小鼠中胃癌。注射后2小时和6小时显影出放射免疫ECT图像。 ECT成像后,处死小鼠,确定其组织和肿瘤放射性分布,并计算注射剂量百分数(%ID / g)和肿瘤/非肿瘤(T / NT)的百分比。高效液相色谱法测定两组小鼠肿瘤组织和血液中5-FU的浓度。结果9〜(99m)Tc-5-FU-Ab-NPs标记的百分率为90。 %〜95%。标记前后抗体活性没有明显降低。放射免疫成像(RII)显示,在注射〜(99m)Tc-5-FU-Ab-NPs 2小时后,肿瘤图像已经显现,并且随着时间的推移在注射后第6小时更加清晰。注射后2小时和6小时,肿瘤组织的%ID / g均显着高于对照组。与注射后2 h相比,注射后6 h实验组的肿瘤%ID / g和肿瘤血液活度比(TB)有所增加,同时,该组小鼠的肿瘤中5-FU浓度升高实验组随着时间的推移持续增加,并且与对照组的5-FU浓度相比有显着差异。结论结论本研究制备的9〜(99m)Tc-5-FU-Ab-NPs足以用于治疗肿瘤。满足RI1的要求,并且抗VEGF MCAB的免疫靶向能力是可靠的。注射后6小时,人胃癌异种移植物中的9〜(99m)Tc-5-FU-Ab-NPs显示出较高的比浓度阴影。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号